Poly-L-Lactic Acid
Review and Evaluation of Treatment Procedures Using Injectable Poly-L-Lactic Acid in the Treatment of Human Immunodeficiency Virus–associated Facial Lipoatrophy
Douglas Mest, MD; Gail Humble, MD, Blue Pacific Aesthetic Medical Group, Hermosa Beach, California Abstract Injectable poly-L-lactic acid is United States Food and Drug Administration–approved for the restoration and/or correction of the signs of lipoatrophy in people with human immunodeficiency virus and for use in immune-competent people for the correction of nasolabial fold contour deficiencies. [...]
Global Volumetric Assessment and Three-dimensional Enhancement of the Face With Injectable Poly-L-lactic Acid
Richard N. Sherman, MD Skin Institute of New Orleans, New Orleans, Louisiana; Clinical Associate Professor, Department of Dermatology, Tulane University, New Orleans, Louisiana Disclosure: Dr. Sherman is a speaker, master trainer, and advisory board member for Sanofi-Aventis U.S. LLC. Editorial support for this article was provided by the editorial staff at Embryon. This article was [...]
fred klumpp |&co
Recent Comments